TECH
Bio-Techne Corp

673
Mkt Cap
$9.01B
Volume
979,878.00
52W High
$79.28
52W Low
$46.01
PE Ratio
118.17
TECH Fundamentals
Price
$58.68
Prev Close
$57.81
Open
$58.64
50D MA
$58.52
Beta
1.14
Avg. Volume
2.22M
EPS (Annual)
$0.4593
P/B
4.58
Rev/Employee
$393,430.65
Loading...
Loading...
News
all
press releases
Rothschild Investment LLC Purchases 17,529 Shares of Bio-Techne Corp $TECH
Rothschild Investment LLC lifted its position in shares of Bio-Techne Corp (NASDAQ:TECH - Free Report) by 1,211.4% during the second quarter, according to the company in its most recent Form 13F...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Banco Bilbao Vizcaya Argentaria S.A. Has $427,000 Stock Position in Bio-Techne Corp $TECH
Banco Bilbao Vizcaya Argentaria S.A. cut its stake in Bio-Techne Corp (NASDAQ:TECH - Free Report) by 37.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·2d ago
News Placeholder
Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand...
PR Newswire·2d ago
News Placeholder
Geode Capital Management LLC Sells 30,889 Shares of Bio-Techne Corp $TECH
Geode Capital Management LLC cut its stake in shares of Bio-Techne Corp (NASDAQ:TECH - Free Report) by 0.8% in the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·2d ago
News Placeholder
Bio-Techne Corp (NASDAQ:TECH) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Bio-Techne Corp (NASDAQ:TECH - Get Free Report) have been given an average rating of "Moderate Buy" by the sixteen brokerages that are covering the company, Marketbeat Ratings reports. One...
MarketBeat·4d ago
News Placeholder
Bio-Techne Corp $TECH Shares Sold by Aviva PLC
Aviva PLC decreased its stake in Bio-Techne Corp (NASDAQ:TECH - Free Report) by 94.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange...
MarketBeat·5d ago
News Placeholder
Resona Asset Management Co. Ltd. Reduces Holdings in Bio-Techne Corp $TECH
Resona Asset Management Co. Ltd. lowered its position in Bio-Techne Corp (NASDAQ:TECH - Free Report) by 96.5% in the 2nd quarter, according to the company in its most recent filing with the SEC. The...
MarketBeat·6d ago
News Placeholder
Vestmark Advisory Solutions Inc. Grows Position in Bio-Techne Corp $TECH
Vestmark Advisory Solutions Inc. lifted its position in Bio-Techne Corp (NASDAQ:TECH - Free Report) by 94.1% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund...
MarketBeat·9d ago
News Placeholder
Bio-Techne Corp $TECH Shares Sold by Jackson Square Partners LLC
Jackson Square Partners LLC cut its stake in Bio-Techne Corp (NASDAQ:TECH - Free Report) by 83.3% in the second quarter, according to its most recent 13F filing with the Securities & Exchange...
MarketBeat·11d ago
News Placeholder
Bio-Techne (NASDAQ:TECH) Given New $70.00 Price Target at UBS Group
UBS Group increased their price target on shares of Bio-Techne from $65.00 to $70.00 and gave the stock a "buy" rating in a research report on Thursday...
MarketBeat·13d ago

Latest TECH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.